Clinical Scorecard: The Profile of Endocannabinoidome Mediators in Human Feces Is Primarily Influenced by Diet and Gut Microbiota
At a Glance
Category
Detail
Condition
Metabolic and intestinal function homeostasis related to endocannabinoidome mediators
Key Mechanisms
Endocannabinoidome (eCBome) mediators including N-acyl-ethanolamines (NAEs) and 2-monoacyl-glycerols (2-MAGs) modulate energy homeostasis and inflammation via multiple receptors; their fecal profiles are influenced by diet and gut microbiota composition
Target Population
Healthy adults with varying adiposity phenotypes
Care Setting
Clinical research and dietary intervention settings
Key Highlights
Six NAEs and seven 2-MAGs were identified in human feces, with some omega-3–derived mediators often undetectable.
Fecal eCBome mediator levels correlate weakly with circulating levels but strongly associate with gut microbiota diversity and composition.
Dietary intake of fiber-rich foods is linked to lower fecal eCBome mediator levels, while unsaturated fatty acid intake correlates with specific fecal 2-MAGs.
Guideline-Based Recommendations
Diagnosis
Profile fecal eCBome mediators using liquid chromatography-tandem mass spectrometry to assess gut lumen eCBome status.
Management
Consider dietary modulation, emphasizing fiber intake and unsaturated fatty acids, to influence fecal eCBome mediator profiles.
Recognize the bidirectional relationship between gut microbiota composition and eCBome signaling in metabolic regulation.
Monitoring & Follow-up
Monitor changes in fecal eCBome mediators alongside dietary interventions and gut microbiota composition to evaluate metabolic and intestinal homeostasis.
Risks
Altered eCBome tone and fecal mediator profiles may associate with visceral adiposity and metabolic disturbances.
Patient & Prescribing Data
Healthy adults with variable adiposity and metabolic profiles
Dietary interventions, such as Mediterranean diet rich in fiber and unsaturated fats, can modify fecal eCBome mediator profiles potentially impacting metabolic health.
Clinical Best Practices
Use comprehensive dietary assessment and gut microbiota profiling to understand determinants of fecal eCBome mediators.
Incorporate fecal eCBome mediator profiling in research and clinical studies investigating metabolic and intestinal health.
Apply controlled dietary interventions to modulate eCBome signaling via gut microbiota and dietary fatty acid intake.
by Sophie Castonguay-Paradis, Lydiane Parent, Gabrielle St-Arnaud, Julie Perron, Élizabeth Dumais, Nicolas Flamand, Frédéric Raymond, Vincenzo Di Marzo, Alain Veilleux
